Factor XIII deficiency in Iran: A comprehensive review of the literature

Seminars in Thrombosis and Hemostasis

Volumn 41, Issue 3, 2015, Pages 323-329

  Dorgalaleh, Akbar ^a   Naderi, Majid ^b   Hosseini, Maryam Sadat ^a   Alizadeh, Shaban ^a   Hosseini, Soudabeh ^c   Tabibian, Shadi ^a   Eshghi, Peyman ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

clinical manifestations; factor XIII deficiency; Iran; molecular spectrum

Indexed keywords

BLOOD CLOTTING FACTOR 13; FRESH FROZEN PLASMA;

BLEEDING TENDENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD SAFETY; BRAIN HEMORRHAGE; CONSANGUINEOUS MARRIAGE; CRYOPRECIPITATE; DELIVERY; GENE MUTATION; HEMATOMA; HETEROZYGOTE; HUMAN; INCIDENCE; IRAN; MENORRHAGIA; NEWBORN CARE; PATIENT CARE; PLASMA TRANSFUSION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT ABORTION; REVIEW; WOUND HEMORRHAGE; BLOOD; CENTRAL NERVOUS SYSTEM DISEASE; FACTOR XIII DEFICIENCY; FEMALE; GENETICS; MALE; MUTATION; NEWBORN; PATHOLOGY; PREGNANCY; QUALITY OF LIFE; TREATMENT OUTCOME; UMBILICAL CORD;

ABORTION, HABITUAL; CENTRAL NERVOUS SYSTEM DISEASES; FACTOR XIII DEFICIENCY; FEMALE; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; IRAN; MALE; MENORRHAGIA; MUTATION; PREGNANCY; PREVALENCE; QUALITY OF LIFE; TREATMENT OUTCOME; UMBILICAL CORD;

EID: 84928040364     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1395350     Document Type: Review

References (35)

1. Levy J. H., Greenberg C. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion: 2013; 53 5 1120 1131
2. Muszbek L., Bereczky Z., Bagoly Z., Komáromi I., Katona É. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev: 2011; 91 3 931 972
3. Peyvandi F., Bolton-Maggs P. H., Batorova A., De Moerloose P. Rare bleeding disorders. Haemophilia: 2012; 18 04 148 153
4. Hsieh L., Nugent D. Rare factor deficiencies. Curr Opin Hematol: 2012; 19 5 380 384
5. Naderi M., Dorgalaleh A., Tabibian Sh, Alizadeh Sh, Eshghi P., Solaimani G. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol: 2013; 3 4 164 172
6. Hsieh L., Nugent D. Factor XIII deficiency. Haemophilia: 2008; 14 6 1190 1200
7. Eshghi P., Cohan N., Naderi M., Karimi M. Factor XIII deficiency: a review of literature. Iranian Journal of Blood and Cancer: 2010; 4 2 85 91
8. Masoum M. G., Hamid R. B., Masoum M. G. Population dynamics in geographic regions of Iran and its consequences. Hum Geogr Res Quart: 2014; 45 4 6 8
9. Naderi M., Imani M., Eshghi P., et al. Factor XIII deficiency in Sistan and Baluchistan province. Sci J Blood Transfus Organ: 2013; 10 3 282 288
10. Iranian Society of Hemophilia (ISH) Available at: http://hemophilia.org.ir. Accessed January 21, 2015
11. Mansouritorghabeh H., Manavifar L., Banihashem A., et al. An investigation of the spectrum of common and rare inherited coagulation disorders in north-eastern Iran. Blood Transfus: 2013; 11 2 233 240
12. Karimi M., Haghpanah S., Amirhakimi A., Afrasiabi A., Dehbozorgian J., Nasirabady S. Spectrum of inherited bleeding disorders in southern Iran, before and after the establishment of comprehensive coagulation laboratory. Blood Coagul Fibrinolysis: 2009; 20 8 642 645
13. Peyvandi F., Tagliabue L., Menegatti M., et al. Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat: 2004; 23 1 98 98
14. Naderi M., Tabibian S., Hosseini M. S., et al. Congenital combined deficiency of coagulation factors: a study of seven patients. Blood Coagul Fibrinolysis: 2014;; doi:10.1097/MBC.0000000000000180
15. Naderi M., Zarei T., Haghpanah S., Eshghi P., Miri-Moghaddam E., Karimi M. Intracranial hemorrhage pattern in the patients with factor XIII deficiency. Ann Hematol: 2014; 93 4 693 697
16. Schroeder V., Kohler H. P. Factor XIII deficiency: an update. Semin Thromb Hemost: 2013; 39 6 632 641
17. Eshghi P., Abolghasemi H., Sanei-Moghaddam E., et al. Factor XIII deficiency in south-east Iran. Haemophilia: 2004; 10 5 470 472
18. Trinh C. H., Sh Elsayed W., Eshghi P., et al. Molecular analysis of sixteen unrelated factor XIIIA deficient families from south-east of Iran. Br J Haematol: 2008; 140 5 581 584
19. Naderi M., Dorgalaleh A., Alizadeh S., Tabibian S., Bamedi T. Diagnosis, clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol: 2014
20. Tamaddon G. H., Kazemi A., Rastegar G., Alla F., Hejazi S. Molecular basis of inherited factor XIII-A deficiency among patients from Sistan-Baluchestan. Zahedan Journal of Research in Medical Sciences: 2010; 11 4 19 24
21. Miri-Moghaddam E., Garmie Y., Naderi M. Unusual Prevalence of c559T> C Mutation in Patients with Factor XIII deficiency in Southeast of Iran. Gene Cell Tissue: 2014; 1 1 e18314
22. Eshghi P., Cohan N., Lak M., et al. Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran. Clin Appl Thromb Hemost: 2012; 18 1 100 103
23. Peyvandi F., Di Michele D., Bolton-Maggs P. H., Lee C. A., Tripodi A., Srivastava A.; Project on Consensus Definitions in Rare Bleeeding Disorders of the Factor VIII/Factor IX Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost: 2012; 10 9 1938 1943
24. Lak M., Peyvandi F., Ali Sharifian A., Karimi K., Mannucci P. M. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost: 2003; 1 8 1852 1853
25. Naderi M., Dorgalaleh A., Tabibian S., et al. Association Between Val34Leu Polymorphism and Risk of Umbilical Cord Bleeding in Severe Congenital Coagulation Factor XIII Deficiency in Southeast of Iran. Gene Cell Tissue: 2014; 1 1 e18360
26. Naderi M., Alizadeh S., Kazemi A., et al. Central nervous system bleeding in pediatric patients with factor XIII deficiency: A study on 23 new cases. Hematology: 2014;; 10.1179/1607845414Y.0000000172
27. Naderi M., Dorgalaleh A., Alizadeh S., et al. Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency. Haemophilia: 2014; 20 1 e89 e92
28. Naderi M., Dorgalaleh A., Alizadeh S., Tabibian S., Taregh B., Karimi M. The PAI-I Gene 4G/5G polymorphism and central nervous system bleeding in factor XIII deficiency. Blood: 2014; 122 21 4782 4782
29. Kadir R., Chi C., Bolton-Maggs P. Pregnancy and rare bleeding disorders. Haemophilia: 2009; 15 5 990 1005
30. Naderi M., Eshghi P., Cohan N., Miri-Moghaddam E., Yaghmaee M., Karimi M. Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran. Haemophilia: 2012; 18 5 773 776
31. Mahmoodi M., Peyvandi F., Afrasiabi A., Ghaffarpasand F., Karimi M. Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis: 2011; 22 5 396 401
32. Naderi M., Eshghi P., Saneei Moghaddam E., et al. Safety of human blood products in rare bleeding disorders in southeast of Iran. Haemophilia: 2013; 19 2 e90 e92
33. Eshghi P., Mahjour S. B., Naderi M., Dehbozorgian J., Karimi M. Long-term prophylaxis in patients with factor XIII deficiency complicated by intracranial haemorrhage in Iran. Haemophilia: 2010; 16 2 383 385
34. Rashidi S. Prevalence of Inhibitor Proteins Level in Factor XIII Deficient Patients Receiving Prophylaxis [dissertation]. Zahedan, IL Zahedan University of Medical sciences: 2014
35. Naderi M., Eshghi P., Cohan N., Haghpanah S., Karimi M. Evaluation of the FXIII deficiency prophylaxis intervals in large number of FXIII deficiency patients from Iran. Haemophilia: 2013; 19 3 e175 e176